Diagnosis of Portal Vein Thrombosis
Doppler ultrasound should be used as the first-line investigation for diagnosing portal vein thrombosis, followed by contrast-enhanced CT scan in the portal phase for confirmation and assessment of extension. 1
Diagnostic Algorithm
Initial Imaging
- Doppler ultrasound is the first imaging procedure of choice when PVT is suspected 1
Confirmatory Imaging
- Contrast-enhanced CT scan should be used to confirm diagnosis and assess extension 1
Alternative/Additional Imaging
- MR imaging can be used as an alternative to CT 1
Important Diagnostic Considerations
Timing of Thrombosis
- Recent thrombus (acute PVT) can be identified by:
Pitfalls to Avoid
- Images acquired during late arterial phase are not optimal for PVT diagnosis 1
- Low portal vein flow can cause delayed contrast arrival, creating a false positive appearance of thrombosis 1
- Acute thrombosis may superimpose on long-standing cavernoma, complicating diagnosis 1
Differential Diagnosis
- Malignant portal vein invasion (especially by hepatocellular carcinoma) 4
- Portal vein constriction (typically by pancreatic cancer or cholangiocarcinoma) 4
- Underlying cirrhosis or obliterative portal venopathy must be established or ruled out 1
Evaluating Complications
- Signs suggestive of intestinal infarction (most concerning complication) include:
Follow-up Imaging
- Perform CT scan at 6-12 months to assess recanalisation of the portal venous system 1
- Screen for gastroesophageal varices in unrecanalised patients 1
- Perform MR imaging cholangiography in patients with persisting cholestasis or biliary tract abnormalities suggestive of portal biliopathy 1
Underlying Causes
- All patients should be investigated for thrombophilic conditions 5
- Common causes include cirrhosis, hepatobiliary malignancy, abdominal infectious/inflammatory diseases, and myeloproliferative disorders 4, 5
By following this diagnostic approach, clinicians can accurately diagnose portal vein thrombosis, assess its extent, identify complications, and guide appropriate treatment decisions to reduce morbidity and mortality.